Oberweis Micro Cap Institutional
OMCIX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Fred Liu
- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 101 North Wacker Drive, Suite 600 Chicago IL United States of America 60606
- IPO Date
- May 1, 2017
- CIK
- 0000803020
- Website
- oberweisfunds.com
- Similar Companies
- Business
- Oberweis Micro Cap Institutional (OMCIX) is an open-end equity mutual fund managed by Oberweis Asset Management, Inc., that seeks capital appreciation by investing principally in the common stocks of micro-cap growth companies with improving growth characteristics and potential for significant long-term earnings growth. Under normal circumstances, the fund invests at least 80% of its net assets in securities of very small companies that, at the time of purchase, have a market capitalization within the range of companies represented in the Russell Microcap Growth Index (typically less than $600 million or aligned with index parameters, whichever is greater); the portfolio, comprising 80-90 holdings, emphasizes sectors such as technology, healthcare, industrials, and consumer cyclical, with top positions including ADMA Biologics, IMAX Corporation, Primoris Services, and Ultra Clean Holdings. The strategy employs behavioral finance principles and rigorous bottom-up fundamental research to identify underappreciated micro-cap firms offering high growth potential, while maintaining diversification and risk management. Oberweis Asset Management, Inc., founded in 1989 and privately held, serves as the investment adviser to OMCIX and the broader Oberweis Funds family, which includes other U.S., global, and international growth-oriented portfolios such as the Small-Cap Opportunities Fund and Micro-Cap Fund investor class (OBMCX). Headquartered at 3333 Warrenville Road, Suite 500, Lisle, Illinois, the firm supports its strategies with equity research teams in New York, London, and Hong Kong, enabling a global perspective on micro-, small-, and mid-cap equities despite OMCIX's primary U.S. geographic focus. The institutional class shares target qualified institutional investors with a minimum investment of $1,000,000, feature an expense ratio of approximately 1.21-1.22%, and exhibit a portfolio turnover of around 51%. In recent developments, Oberweis Asset Management proposed and executed reorganizations within its fund family, including the 2023 combination of the Oberweis Emerging Growth Fund into the Global Opportunities Fund and a similar merger of one international opportunities fund into another to streamline operations and fee structures, enhancing efficiency across multi-class structures without altering core investment objectives. No major funding rounds, acquisitions, or new product launches specific to OMCIX were reported in the last 1-2 years, though the firm continues to emphasize its disciplined process amid a focus on micro-cap inefficiencies for alpha generation over full market cycles. These changes reflect ongoing portfolio and operational optimizations by the adviser.